US Bancorp’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
2023
Q2
$905K Sell
2023
Q1
$877K Buy
2022
Q4
$26.6K Buy
2022
Q3
$14K Sell
2022
Q2
$41K Sell
2022
Q1
$60K Buy
2021
Q4
$5K Buy
2021
Q3
$9K Sell
2021
Q2
$89K Sell
2021
Q1
$81K Sell
2020
Q4
$127K Buy
2020
Q3
$71K Buy
2020
Q2
$105K Sell
2020
Q1
$101K Buy
2019
Q4
$50K Buy
2019
Q3
$1K Buy